ABUS R&D Expenses
Arbutus Biopharma Corp · R&D Expenses
ABUS R&D Expenses
Latest reported$17.80Mperiod ending
ABUS TTM R&D Expenses ($10.71M → $17.80M)
TTM R&D Expenses
High-resolution chart · PNG
ABUS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 17,802,000 | |
| 20,402,000 | |
| 25,241,000 | |
| 29,045,000 | |
| 37,540,000 | |
| 47,593,000 | |
| 54,037,000 | |
| 62,791,000 | |
| 68,687,000 | |
| 70,828,000 | |
| 73,700,000 | |
| 79,085,000 | |
| 78,971,000 | |
| 84,221,000 | |
| 84,408,000 | |
| 80,671,000 | |
| 77,325,000 | |
| 70,182,000 | |
| 65,502,000 | |
| 62,682,000 | |
| 58,038,000 | |
| 52,704,000 | |
| 49,338,000 | |
| 89,200,000 | |
| 94,866,000 | |
| 97,141,000 | |
| 101,437,000 | |
| 56,246,000 | |
| 55,081,000 | |
| 58,697,000 | |
| 57,934,000 | |
| 64,693,000 | |
| 63,664,000 | |
| 62,753,000 | |
| 62,676,000 | |
| 62,010,000 | |
| 62,211,000 | |
| 61,981,000 | |
| 61,253,000 | |
| 59,001,000 | |
| 59,617,000 | |
| 54,102,000 | |
| 51,515,000 | |
| 48,513,000 | |
| 41,468,000 | |
| 41,066,000 | |
| 38,713,000 | |
| 33,805,398 | |
| 29,993,765 | |
| 25,505,722 | |
| 21,418,689 | |
| 18,031,732,424,291 | |
| 18,031,730,075,889 | |
| 18,031,725,265,932 | |
| 18,031,721,148,965 | |
| 3,148,965 | |
| 0 | |
| 0 | |
| 0 | |
| 22,133,977,938,338 | |
| 22,133,982,999,999 | |
| 22,133,982,999,999 | |
| 22,133,982,999,999 | |
| 5,061,661 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 5,145,406 | |
| 10,714,955 | |
| 10,714,955 | |
| 13,764,657 | |
| 11,809,644 | |
| 7,190,140 |